✦ LIBER ✦

Epidemiological aspects of inhibitor development redefine the clinical importance of inhibitors

✍ Scribed by van den Berg, H. M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunological aspects of inhibitor devel

✍ M. T. REDING 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 565 KB

The clinical development of MEK inhibito

✍ Zhao, Yujie; Adjei, Alex A. 📂 Article 📅 2014 🏛 Nature Publishing Group 🌐 English ⚖ 918 KB

Developments of the fluoropyrimidines as

✍ David Machover 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 759 KB

Clinical Importance of Metalloproteinase

✍ STEPHEN M. KRANE 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 671 KB

Pre-clinical development of farnesyltran

✍ Robert B. Lobell; Nancy E. Kohl 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 603 KB

Clinical aspects of a specific GABA upta

✍ Mengel, H.B.; Christensen, M.S. 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 182 KB